EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY Q3区

期刊简介

The European Journal of Clinical Pharmacology publishes original papers on all aspects of clinical pharmacology and drug therapy in humans. Manuscripts are welcomed on the following topics: therapeutic trials, pharmacokinetics/pharmacodynamics, pharmacogenetics, drug metabolism, adverse drug reactions, drug interactions, all aspects of drug development, development relating to teaching in clinical pharmacology, pharmacoepidemiology, and matters relating to the rational prescribing and safe use of drugs. Methodological contributions relevant to these topics are also welcomed.Data from animal experiments are accepted only in the context of original data in man reported in the same paper. EJCP will only consider manuscripts describing the frequency of allelic variants in different populations if this information is linked to functional data or new interesting variants. Highly relevant differences in frequency with a major impact in drug therapy for the respective population may be submitted as a letter to the editor.Straightforward phase I pharmacokinetic or pharmacodynamic studies as parts of new drug development will only be considered for publication if the paper involves-a compound that is interesting and new in some basic or fundamental way, or-methods that are original in some basic sense, or-a highly unexpected outcome, or-conclusions that are scientifically novel in some basic or fundamental sense.

《欧洲临床药理学杂志》发表了关于人类临床药理学和药物治疗各个方面的原创论文。欢迎您就以下主题提交稿件：治疗试验、药代动力学/药效学、药物遗传学、药物代谢、药物不良反应、药物相互作用、药物开发的各个方面、与临床药理学教学相关的开发、药物流行病学以及与合理处方和安全使用药物相关的事项。与这些主题相关的方法学贡献也受到欢迎。来自动物实验的数据仅在同一篇论文中报告的人类原始数据的背景下接受。EJCP只会考虑描述不同人群中等位基因变异频率的手稿，如果这些信息与功能数据或新的有趣变异有关。对相应人群的药物治疗有重大影响的频率差异可能以信函形式提交给编辑。作为新药开发一部分的简明I期药代动力学或药效学研究，只有在论文涉及的化合物在某些基本或基础方面是有趣的和新的，或方法在某些基本意义上是原创的，或者-非常出乎意料的结果，或者-在一些基本或根本意义上的科学新颖的结论。

《EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY》期刊已被查看： 次

期刊官网投稿信息

分区信息

• 上一篇： Environment Protection Engineering
• 下一篇：Fetal and Pediatric Pathology